Valneva SE
VLA15
Lyme disease
Resolved
7days ago
Phase 3 readout · Jun 30, 2026
What's at stake
Phase 3 trial results for VLA15 in Lyme disease are due Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 14h ago
“Phase 3 vaccinations were completed in 2025 and VALOR trial results are expected to be reported in the first half of 2026.”